Crenolanib

Synopsis, Chemistry

INTERMEDIATES

2 Suppliers

2 Suppliers

DIGITAL CONTENT

1 News

1 News

API SUPPLIERS

API Suppliers

US DMFs Filed

CEP/COS Certifications

JDMFs Filed

EU WC

Listed Suppliers

API REF. PRICE (USD / KG)

API Market Place

INTERMEDIATES

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

FDF Market Place

EXCIPIENTS

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

Other Listed Suppliers

SERVICES

Also known as: 670220-88-9, Crenolanib (cp-868596), Cp-868596, Aro-002, Crenolanib [usan], Cp-868,596

Molecular Formula

C₂₆H₂₉N₅O₂

Molecular Weight

443.5 g/mol

InChI Key

DYNHJHQFHQTFTP-UHFFFAOYSA-N

FDA UNII

LQF7I567TQ

Crenolanib is an orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with potential antineoplastic activity. Upon oral administration, crenolanib binds to and inhibits both wild-type and mutated forms of PDGFR and Flt3, which may result in the inhibition of PDGFR- and Flt3-related signal transduction pathways. This results in inhibition of tumor angiogenesis and tumor cell proliferation in PDGFR and/or Flt3 overexpressing tumor cells. PDGFR and Flt3, class III receptor tyrosine kinases, are upregulated or mutated in many tumor cell types.

1 2D Structure

Crenolanib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine

2.1.2 InChI

InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3

2.1.3 InChI Key

DYNHJHQFHQTFTP-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4

2.2 Other Identifiers

2.2.1 UNII

LQF7I567TQ

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Cp-868,596

2.3.2 Depositor-Supplied Synonyms

1. 670220-88-9

2. Crenolanib (cp-868596)

3. Cp-868596

4. Aro-002

5. Crenolanib [usan]

6. Cp-868,596

7. Aro 002

8. Cp 868596

9. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine

10. Lqf7i567tq

11. Cp868569

12. Crenolanib (usan)

13. Mfcd21609260

14. 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine

15. 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1h-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine

16. 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine

17. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine.

18. 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1h-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine

19. Cp-868

20. Cp868596

21. Crenolanib [usan:inn]

22. Unii-lqf7i567tq

23. Crenolanibum

24. Cp-868596 (crenolanib)

25. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzimidazol-1-yl)quinolin-8-yl)piperidin-4-amine

26. 6t2

27. Cp-868569

28. Crenolanib [inn]

29. Crenolanib,cp-868596

30. [1-[2-[5-(3-methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine

31. Crenolanib [who-dd]

32. Mls006010956

33. Crenolanib - Cp-868569

34. Gtpl7882

35. Schembl2730601

36. Chembl2105728

37. Dtxsid50985873

38. Ex-a215

39. Chebi:145365

40. Bdbm185149

41. Hms3656f19

42. Bcp02384

43. Zinc3820043

44. Nsc763526

45. Nsc800079

46. S2730

47. Akos026750597

48. Bcp9000551

49. Ccg-264988

50. Cs-0566

51. Db11832

52. Nsc-763526

53. Nsc-800079

54. Sb16603

55. Ncgc00346658-01

56. Ncgc00346658-09

57. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine

58. Ac-32071

59. As-57698

60. Hy-13223

61. Smr004702760

62. Sy237889

63. Ft-0665221

64. Sw218293-2

65. D10102

66. J-502712

67. Q5184160

68. Cp-868596;cp 868596;cp868596;aro 002

69. 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1h-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine

70. 1-{2-[5-(3-methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine

71. 4-piperidinamine, 1-(2-(5-((3-methyl-3-oxetanyl)methoxy)-1h-benzimidazol-1-yl)-8-quinolinyl)-

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₂₉N₅O₂
Molecular Weight	443.5 g/mol
XLogP3	3.7
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	5
Exact Mass	443.23212518 g/mol
Monoisotopic Mass	443.23212518 g/mol
Topological Polar Surface Area	78.4 Å²
Heavy Atom Count	33
Formal Charge	0
Complexity	667
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1